This company has been marked as potentially delisted and may not be actively trading. Zafgen (ZFGN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ZFGN vs. GOSS, TSVT, TERN, PVLA, NATR, INZY, VNDA, LFCR, AVIR, and NGNEShould you be buying Zafgen stock or one of its competitors? The main competitors of Zafgen include Gossamer Bio (GOSS), 2seventy bio (TSVT), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Nature's Sunshine Products (NATR), Inozyme Pharma (INZY), Vanda Pharmaceuticals (VNDA), Lifecore Biomedical (LFCR), Atea Pharmaceuticals (AVIR), and Neurogene (NGNE). These companies are all part of the "medical" sector. Zafgen vs. Gossamer Bio 2seventy bio Terns Pharmaceuticals Palvella Therapeutics Nature's Sunshine Products Inozyme Pharma Vanda Pharmaceuticals Lifecore Biomedical Atea Pharmaceuticals Neurogene Gossamer Bio (NASDAQ:GOSS) and Zafgen (NASDAQ:ZFGN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk. Do institutionals & insiders believe in GOSS or ZFGN? 81.2% of Gossamer Bio shares are held by institutional investors. Comparatively, 70.4% of Zafgen shares are held by institutional investors. 6.7% of Gossamer Bio shares are held by insiders. Comparatively, 14.2% of Zafgen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media favor GOSS or ZFGN? In the previous week, Gossamer Bio had 3 more articles in the media than Zafgen. MarketBeat recorded 3 mentions for Gossamer Bio and 0 mentions for Zafgen. Gossamer Bio's average media sentiment score of 1.33 beat Zafgen's score of 0.00 indicating that Gossamer Bio is being referred to more favorably in the media. Company Overall Sentiment Gossamer Bio Positive Zafgen Neutral Does the MarketBeat Community favor GOSS or ZFGN? Zafgen received 188 more outperform votes than Gossamer Bio when rated by MarketBeat users. Likewise, 68.59% of users gave Zafgen an outperform vote while only 67.09% of users gave Gossamer Bio an outperform vote. CompanyUnderperformOutperformGossamer BioOutperform Votes15767.09% Underperform Votes7732.91% ZafgenOutperform Votes34568.59% Underperform Votes15831.41% Is GOSS or ZFGN more profitable? Zafgen's return on equity of -51.34% beat Gossamer Bio's return on equity.Company Net Margins Return on Equity Return on Assets Gossamer BioN/A -127.28% -22.12% Zafgen N/A -51.34%-34.55% Which has more risk and volatility, GOSS or ZFGN? Gossamer Bio has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, Zafgen has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Which has higher earnings and valuation, GOSS or ZFGN? Zafgen has lower revenue, but higher earnings than Gossamer Bio. Gossamer Bio is trading at a lower price-to-earnings ratio than Zafgen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGossamer Bio$124.59M2.43-$179.82M-$0.23-5.78ZafgenN/AN/A-$45.41M-$1.07-2.50 Do analysts recommend GOSS or ZFGN? Gossamer Bio currently has a consensus target price of $7.75, suggesting a potential upside of 482.71%. Given Gossamer Bio's stronger consensus rating and higher possible upside, equities research analysts plainly believe Gossamer Bio is more favorable than Zafgen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gossamer Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Zafgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryGossamer Bio beats Zafgen on 10 of the 16 factors compared between the two stocks. Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZFGN vs. The Competition Export to ExcelMetricZafgenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$100.42M$6.71B$5.52B$8.59BDividend YieldN/A2.49%5.27%4.18%P/E Ratio-2.798.7027.2420.13Price / SalesN/A249.96408.56162.22Price / CashN/A65.8538.2534.64Price / Book1.996.586.974.69Net Income-$45.41M$143.49M$3.23B$248.08M Zafgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZFGNZafgenN/A$2.68+8.9%N/A-72.1%$100.42MN/A-2.7938Gap UpHigh Trading VolumeGOSSGossamer Bio3.9715 of 5 stars$1.20+3.4%$7.75+545.8%+142.5%$272.76M$124.59M-3.75180Gap DownTSVT2seventy bio0.902 of 5 stars$5.00flat$4.25-15.0%N/A$266.15M$48.37M-2.69440Positive NewsTERNTerns Pharmaceuticals3.9795 of 5 stars$3.02+2.7%$15.63+417.4%-48.3%$263.76MN/A-2.5640Positive NewsPVLAPalvella Therapeutics3.9016 of 5 stars$23.72+7.3%$46.29+95.1%N/A$262.25M$42.81M-1.96N/APositive NewsGap UpHigh Trading VolumeNATRNature's Sunshine Products3.1919 of 5 stars$14.27-1.0%$18.33+28.5%-3.5%$261.87M$456.62M16.22850Positive NewsGap DownINZYInozyme Pharma2.5615 of 5 stars$3.96flat$11.75+196.7%-13.8%$255.67MN/A-2.5450VNDAVanda Pharmaceuticals4.5874 of 5 stars$4.33+2.1%$16.50+281.1%-24.7%$255.18M$201.35M-13.53290Positive NewsLFCRLifecore Biomedical1.6447 of 5 stars$6.72+0.7%$8.00+19.0%+15.9%$248.81M$130.31M-12.00690AVIRAtea Pharmaceuticals2.5307 of 5 stars$2.90+1.8%$6.00+106.9%-14.1%$248.18MN/A-1.4070NGNENeurogene3.3262 of 5 stars$17.28-4.2%$44.60+158.1%-42.4%$246.45M$925,000.00-3.9790Gap Down Related Companies and Tools Related Companies GOSS Alternatives TSVT Alternatives TERN Alternatives PVLA Alternatives NATR Alternatives INZY Alternatives VNDA Alternatives LFCR Alternatives AVIR Alternatives NGNE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZFGN) was last updated on 6/9/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZFGN Stock Free ZFGN Stock Alerts